Woodmont Investment Counsel LLC raised its position in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 27.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 27,514 shares of the financial services provider's stock after buying an additional 5,915 shares during the quarter. Woodmont Investment Counsel LLC's holdings in Aflac were worth $3,059,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Whipplewood Advisors LLC acquired a new position in Aflac in the 4th quarter worth approximately $26,000. BankPlus Trust Department purchased a new stake in shares of Aflac in the fourth quarter valued at $34,000. Curio Wealth LLC purchased a new stake in shares of Aflac in the fourth quarter valued at $36,000. OFI Invest Asset Management acquired a new stake in shares of Aflac in the fourth quarter worth $38,000. Finally, Capital A Wealth Management LLC purchased a new position in shares of Aflac during the fourth quarter valued at $38,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several brokerages recently issued reports on AFL. JPMorgan Chase & Co. increased their price objective on Aflac from $94.00 to $96.00 and gave the stock a "neutral" rating in a research note on Wednesday, April 2nd. Barclays increased their price target on shares of Aflac from $95.00 to $96.00 and gave the stock an "underweight" rating in a research report on Thursday, May 1st. Piper Sandler lifted their target price on shares of Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Wall Street Zen cut shares of Aflac from a "hold" rating to a "sell" rating in a report on Monday, May 5th. Finally, Wells Fargo & Company upped their price target on shares of Aflac from $102.00 to $103.00 and gave the stock an "equal weight" rating in a research note on Tuesday, May 6th. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $104.93.
View Our Latest Stock Analysis on AFL
Insider Activity
In other Aflac news, Director Arthur Reginald Collins sold 2,750 shares of the stock in a transaction on Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the completion of the transaction, the director now directly owns 6,728 shares in the company, valued at $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the business's stock in a transaction on Thursday, May 8th. The shares were sold at an average price of $106.79, for a total transaction of $106,790.00. Following the completion of the sale, the director now owns 26,096 shares in the company, valued at $2,786,791.84. This represents a 3.69% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 40,750 shares of company stock worth $4,304,295. Corporate insiders own 0.90% of the company's stock.
Aflac Stock Up 0.7%
AFL opened at $103.31 on Friday. The business has a 50 day moving average of $104.91 and a 200-day moving average of $105.27. The stock has a market capitalization of $55.85 billion, a price-to-earnings ratio of 16.14, a P/E/G ratio of 3.18 and a beta of 0.82. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1-year low of $88.00 and a 1-year high of $115.50.
Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, April 30th. The financial services provider reported $1.66 EPS for the quarter, missing the consensus estimate of $1.67 by ($0.01). Aflac had a net margin of 21.27% and a return on equity of 15.55%. The company had revenue of $3.40 billion for the quarter, compared to analyst estimates of $4.53 billion. During the same quarter in the previous year, the company earned $1.66 earnings per share. Aflac's revenue for the quarter was down 37.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 2nd. Stockholders of record on Wednesday, May 21st were paid a $0.58 dividend. This represents a $2.32 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date of this dividend was Wednesday, May 21st. Aflac's dividend payout ratio is 36.25%.
Aflac Profile
(
Free Report)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.